IBI3002
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for IBI3002, covering 2025-05-28 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]